Cadazolid is an experimental antibiotic of the oxazolidinone class made by Actelion Pharmaceuticals Ltd. which is effective against Clostridioides difficile...
5 KB (312 words) - 19:25, 20 October 2024
discontinued in 2017 due to its non-superiority to current therapies. Cadazolid Fidaxomicin Ridinilazole SCHEMBL19952957 "Surotomycin Fact Sheet" (PDF)...
5 KB (153 words) - 18:55, 20 October 2024
Cabometyx cabotegravir cabozantinib (USAN, INN) Cabtreo cactinomycin (INN) cadazolid (INN) cadexomer (INN) Cadivast cadralazine (INN) Caduet Caelyx cafaminol...
16 KB (757 words) - 05:06, 19 June 2024
orphan disease. Late-stage drugs in development by Actelion include: Cadazolid for Clostridioides difficile-associated diarrhea Macitentan for pediatric...
25 KB (2,584 words) - 21:16, 20 October 2024
designation adds five more years of exclusivity for ridinazole upon approval. Cadazolid Fidaxomicin SCHEMBL19952957 Surotomycin Cho JC, Crotty MP, Pardo J (March...
6 KB (520 words) - 16:05, 6 June 2023
medications for the treatment of antibiotic-resistant infections in humans. Cadazolid Fidaxomicin Ridinilazole Surotomycin US 10662164, Chang M, Mobashery S...
4 KB (256 words) - 18:21, 21 October 2024